Your browser doesn't support javascript.
loading
Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
Parham, Laura R; Briley, Linda P; King, Karen S; Byrne, Julie; Rappold, Erica; Goss, Paul E; Spraggs, Colin F.
Afiliação
  • Parham LR; PAREXEL International, Research Triangle Park, NC, USA (previously employed by GlaxoSmithKline; work performed on this publication done while employed by GlaxoSmithKline).
  • Briley LP; PAREXEL International, Research Triangle Park, NC, USA (previously employed by GlaxoSmithKline; work performed on this publication done while employed by GlaxoSmithKline).
  • King KS; PAREXEL International, Research Triangle Park, NC, USA (previously employed by GlaxoSmithKline; work performed on this publication done while employed by GlaxoSmithKline).
  • Byrne J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA (previously employed by GlaxoSmithKline; work performed on this publication done while employed by GlaxoSmithKline).
  • Rappold E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA (previously employed by GlaxoSmithKline; work performed on this publication done while employed by GlaxoSmithKline).
  • Goss PE; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Spraggs CF; GlaxoSmithKline Research & Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.
Pharmacogenomics ; 16(11): 1227-9, 2015.
Article em En | MEDLINE | ID: mdl-26265235
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Toxidermias / Antígenos HLA / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Toxidermias / Antígenos HLA / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article